Cargando…
Extent of radiological response does not reflect survival in primary central nervous system lymphoma
BACKGROUND: In primary central nervous system lymphoma (PCNSL), small enhancing lesions can persist after treatment. It is unknown whether a difference in response category (complete response [CR], complete response unconfirmed [CRu], or partial response [PR]) reflects survival. We aimed to determin...
Autores principales: | van der Meulen, Matthijs, Postma, Alida A, Smits, Marion, Bakunina, Katerina, Minnema, Monique C, Seute, Tatjana, Cull, Gavin, Enting, Roelien H, van der Poel, Marjolein, Stevens, Wendy B C, Brandsma, Dieta, Beeker, Aart, Doorduijn, Jeanette K, Issa, Samar, van den Bent, Martin J, Bromberg, Jacoline E C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883767/ https://www.ncbi.nlm.nih.gov/pubmed/33615224 http://dx.doi.org/10.1093/noajnl/vdab007 |
Ejemplares similares
-
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021) -
P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY
por: Doorduijn, J., et al.
Publicado: (2022) -
The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020) -
Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020) -
Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
por: van der Meulen, Matthijs, et al.
Publicado: (2020)